Effect of treatment regimen of the rheumatoid arthritis patients on the risk of coronavirus disease 2019 by modulating the inflammatory mediators.

Bagheri-Hosseinabadi, Zahra; Dehghani, Alireza; Lotfi, Mohammad Amin; Abbasifard, Mitra

Bagheri-Hosseinabadi, Zahra; Dehghani, Alireza; Lotfi, Mohammad Amin; Abbasifard, Mitra.

Afiliación

Bagheri-Hosseinabadi Z; Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Dehghani A; Department of Clinical Biochemistry, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Lotfi MA; Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Abbasifard M; Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Inflammopharmacology ; 31(6): 3021-3028, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37453023

Asunto(s)

Artritis Reumatoide; COVID-19; Humanos; Etanercept/uso terapéutico; Mediadores de Inflamación/análisis; Interleucina-6; Estudios Retrospectivos; Estudios Transversales; Prueba de COVID-19; Citocinas; Factor de Necrosis Tumoral alfa

Palabras clave

Coronavirus disease 2019; Cytokine; Etanercept; Inflammation; Rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Reumatoide / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Inflammopharmacology Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google